MEDIPAL HOLDINGS CORPORATION announced an upward revision to its full-year consolidated forecast for the fiscal year ending March 2027, with net income attributable to owners of the parent expected to exceed its previous forecast by ¥10 billion. Forecasts for net sales and profit were also revised, and earnings per share are expected to be ¥258.92.
MEDIPAL HOLDINGS CORPORATION revised upward its full-year earnings forecast for the fiscal year ending March 2027. Under the new forecast, net sales are projected at ¥394.4 million, operating profit at ¥53.5 billion, ordinary profit at ¥67.5 billion, and net income attributable to owners of the parent at ¥53 billion, an increase of ¥10 billion. Earnings per share are expected to be ¥258.92. Changes from the previous forecast are shown in parentheses.
The company cited gains on the sale of investment securities associated with the reduction of policy shareholdings as a factor behind the upward revision. As a result, net income attributable to owners of the parent for the full-year consolidated results for the fiscal year ending March 2027 is expected to exceed the previous forecast.